期刊文献+

肉桂酰胺格尔德霉素的体内外抗肿瘤活性

Anticancer effect of 17-(6-cinnamamido-hexylamino-)-17-demethoxygeldanamycin:in vitro and in vivo
原文传递
导出
摘要 探讨化合物肉桂酰胺格尔德霉素(CDG)的体内外抗肿瘤活性。采用MTT法检测肿瘤细胞增殖。免疫荧光法和Annexin V-FITC/PI双染法检测肿瘤细胞凋亡,Transwell法检测肿瘤细胞迁移能力,Western blotting法检测肿瘤细胞中RAF.1、EGFR、AKT、CDK4、HER.2蛋白水平。使用异种移植瘤裸鼠模型检测CDG对人乳腺癌MCF-7细胞的生长抑制作用。结果表明:CDG对不同肿瘤细胞增殖具有抑制作用,IC50为13.6~67.4btg·mL-1;CDG能够诱导肿瘤细胞凋亡,引起多种细胞形态学改变;同时,CDG还可降低肿瘤细胞迁移能力,减少RAF-1、EGFR、AKT、CDK4、HER.2蛋白水平;体内实验结果显示,CDG毒性明显低于格尔德霉素(GDM),并且能够抑制人乳腺癌MCF-7裸鼠移植瘤生长。 In the present study, a new compound named 17-(6-cinnamamido-hexylamino-)-17-de- methoxygeldanamycin (CDG) was obtained by introducing the cinnamic acid (CA) group into the 17-site of geldanamycin (GDM). The anti-cancer effects of CDG in vitro and in rive were evaluated. MTT assay was used to examine the inhibitory effect of CDG on the proliferation of MCF-7, HepG2, H460 and SW1990 cells. Immunofluorescent staining flow cytometry combined with Annexin V-FITC/PI staining were used to detect apoptotic cells. Transwell assay was used to analyze the effect of CDG on cell invasion and migration ability. Western blotting was used to detect the expression levels of RAF-1, EGFR, AKT, CDK4 and HER-2 of MCF-7, HepG2 and H460 cells. The toxicities of CDG and GDM were evaluated in mice. Using the subcutaneously transplanted MCF-7 xenograft in nude mice, inhibitory effect was evaluated in rive. The results showed that CDG inhibited the proliferation of cancer cells (ICs0:13.6-67.4 }~g.mL-1). After exposure to CDG for 48 h, most cells presented typical morphologic changes of apoptosis such as chromatin condensation or shrunken nucleus. The rates of apoptosis of MCF-7, HepG2, H460 and SW1990 cells incubated with 10 }~g.mL-l CDG were 23.16%, 27.55%, 22.21%, 20.47%, respectively. A dose-dependent reduction of migration of four cell lines was found after exposure to CD(3. The decreased levels of RAF- 1, EGFR, AKT, CDK4 and HER-2 showed that CDG possessed HSP90 inhibitory effect. The result of animal toxicity test on the mice suggested that CDG had lower toxicity than GDM. Meanwhile, CDG inhibited the growth of MCF-7 xenografts of athymic mice.
出处 《药学学报》 CAS CSCD 北大核心 2013年第12期1771-1777,共7页 Acta Pharmaceutica Sinica
基金 国家“重大新药创制”科技重大专项资助项目(2010zx09401-407)
关键词 肉桂酰胺 格尔德霉素 HSP90抑制剂 抗肿瘤药物 cinnamamide geldanamycin HSP90 inhibitor anticancer drug
  • 相关文献

参考文献2

二级参考文献11

  • 1Melinda Hollingshead,Michael Alley,Angelika M. Burger,Suzanne Borgel,Christine Pacula-Cox,Heinz-Herbert Fiebig,Edward A. Sausville.In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative[J].Cancer Chemotherapy and Pharmacology.2005(2)
  • 2D.B.Solit,N.Rosen. Curt.Top.Med.Chem . 2006
  • 3Z.Y.Liao,S.H.Zhang,Y.S.Zhen. Acta Pharma.Sin . 2001
  • 4.
  • 5De,Boer,C,Meulman,PA,Wnuk,RJ,Peterson,DH.Geldanamycin, a new antibiotic[].Journal of Antibiotics.1970
  • 6Whitesell L,Mimnaugh EC,Costa BD,et al.Inhibition of heat shock protein HSP2pp60v2src heteroprotein complex fomation in benzoquinone ansamycins:essential role for stress proteins in oncogeneic transformation[CAN J][].Proceedings of the National Academy of Sciences of the United States of America.1994
  • 7Sethi V S,Burton S S,Jackson D V.Cancer Chemother[].Pharmacology.1980
  • 8Jiang X F,Shang B Y,Jin L F,et al.Antitumor components from an actinomycete strain 6011W[].Journal of Asian Natural Products Research.1999
  • 9Sethi V S,Burton S S,Jackson D V.Cancer Chemother[].Pharmacology.1980
  • 10陶佩珍,娄志贤,姚天爵,张兴权,线素文,姚恩泰,刘玉珍,王淑琴.广谱抗病毒抗生素17997体内外抗病毒活性研究[J].中国抗生素杂志,1997,22(5):368-372. 被引量:42

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部